CYCLACEL PHARMACEUTICALS INC - COM (CYCC)

CUSIP: 23254L603

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
1,165,085
Share change
-929,540
Total reported value
$407,364
Price per share
$0.35
Number of holders
21
Value change
-$405,924
Number of buys
6
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 23254L603?
CUSIP 23254L603 identifies CYCC - CYCLACEL PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q3 2023

As of 30 Sep 2023, CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,165,085 shares. The largest 10 holders included ACADIAN ASSET MANAGEMENT LLC, Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, KPP Advisory Services LLC, MILLENNIUM MANAGEMENT LLC, Schonfeld Strategic Advisors LLC, and Raymond James Financial Services Advisors, Inc.. This page lists 21 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.